P018 Anti-Carbamylated Protein Antibodies as a Clinical Response Predictor in Rheumatoid Arthritis Patients Treated With Abatacept

doi 10.1136/annrheumdis-2018-ewrr2019.13

Full Text

Abstract

Available in

Date

March 1, 2019

Authors

Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Clinical and Etiological Meaning of Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis

Immunological Medicine

English

NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab

Biologics: Targets and Therapy

Gastroenterology

English

A5.4 Anti Carbamylated Protein Antibodies (Anti-CarP) Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis

Annals of the Rheumatic Diseases

Molecular Biology

English

P037 Anti-Carbamylated Protein Antibodies: Are They Useful for the Diagnosis of Rheumatoid Arthritis?

English

Anti-Carbamylated Protein Antibody Levels Correlate With Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis

Journal of Rheumatology

English

Anti-Drug Antibodies in Colombian Patients With Rheumatoid Arthritis Treated With Enbrel vs Etanar – Preliminary Report

Journal of Immunotoxicology

English

Anti-Carbamylated Protein Antibodies Presence in Early Arthritis With a Poorer Clinical and Radiological Outcome: Data From the French ESPOIR Cohort

Arthritis and Rheumatology

English

Autoantibody Formation in Patients With Rheumatoid Arthritis Treated With Anti-TNF

Annals of the Rheumatic Diseases

Molecular Biology

English

Effects of Abatacept on Monocytes in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases

Molecular Biology

English